Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR3 | P29371 | 11/20 | 0.69 |
| ▸ | TACR1 | P25103 | 10/20 | 0.69 |
| ▸ | TACR2 | P21452 | 3/20 | 0.69 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.33 |
| ▸ | GPR119 | Q8TDV5 | 3/20 | 0.33 |
| ▸ | CCR5 | P51681 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | HTR2A | P28223 | 1/20 | 0.32 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.32 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.32 |
| ▸ | CCR2 | P41597 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3272281 | 0.94 | TACR3 (0.77) | TACR3TACR1TACR2HRH3KCNH2 | |
| SCHEMBL296366 | 0.89 | TACR3 (0.68) | TACR3TACR1TACR2HRH3KCNH2 | |
| SCHEMBL3276349 | 0.86 | TACR3 (0.80) | TACR3TACR1TACR2KCNH2CCR5 | |
| SCHEMBL296171 | 0.82 | TACR3 (1.00) | TACR3TACR1TACR2KCNH2GPR119 | |
| SCHEMBL299474 | 0.82 | TACR3 (1.00) | TACR3TACR1TACR2KCNH2GPR119 | |
| SCHEMBL931920 | 0.82 | TACR3 (1.00) | TACR3TACR1TACR2KCNH2GPR119 | |
| SCHEMBL296428 | 0.82 | TACR3 (0.63) | TACR3TACR1TACR2HRH3KCNH2 | |
| SCHEMBL296922 | 0.82 | TACR3 (0.66) | TACR3TACR1TACR2KCNH2GPR119 | |
| SCHEMBL295707 | 0.81 | TACR3 (0.89) | TACR3TACR1TACR2KCNH2GPR119 | |
| SCHEMBL296834 | 0.81 | TACR3 (0.83) | TACR3TACR1TACR2HRH3KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2200982-A1 | PIPERIDINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS | F. Hoffmann-Roche AG (CH) | 2010-06-30 | — | — | EP | claimed |
| WO-2009033995-A1 | PIPERIDINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2009-03-19 | — | — | WO | claimed |
| EP-2200982-A1 | PIPERIDINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS | F. Hoffmann-Roche AG (CH) | 2010-06-30 | — | — | EP | disclosed |
| WO-2009033995-A1 | PIPERIDINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2009-03-19 | — | — | WO | disclosed |